REPLIGEN CORP·4

Jul 17, 4:40 PM ET

Garland Jason K 4

4 · REPLIGEN CORP · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Repligen CFO Jason Garland Sells 530 Shares

What Happened
Jason K. Garland, Chief Financial Officer of Repligen Corp (RGEN), sold 530 shares of company stock on July 16, 2026, at $150.00 per share, for a total proceeds of $79,500. This was a sale (disposition), not a purchase.

Key Details

  • Transaction date and price: July 16, 2026 — 530 shares at $150.00 each.
  • Total value: $79,500.
  • Shares owned after transaction: Not specified in this Form 4 filing.
  • Footnote: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.
  • Filing/timeliness: Form filed July 17, 2026 (timely relative to the reported transaction).

Context
Sales executed under a 10b5-1 plan are pre-arranged trades and are generally treated as routine rather than a direct signal of the insider’s current view. For retail investors, purchases often carry more informational weight than small open-market sales; this transaction represents a modest $79.5k disposition by the CFO.

Insider Transaction Report

Form 4
Period: 2026-07-16
Transactions
  • Sale

    Common Stock

    [F1]
    2026-07-16$150.00/sh530$79,50018,829 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.
Signature
/s/ Jennifer Carmichael (Attorney in Fact)|2026-07-17

Documents

1 file
  • 4
    ownership.xmlPrimary

    4